LAG 3 Inhibitor Markets, 2028
04 févr. 2022 05h53 HE
|
Research and Markets
Dublin, Feb. 04, 2022 (GLOBE NEWSWIRE) -- The "Global LAG 3 Inhibitor Clinical Trials & Market Opportunity Insight 2028" report has been added to ResearchAndMarkets.com's offering. The emerging...
Global Clinical Research Services Market Research Report (2021 to 2027) - by Services, Indication, Deployment, End-user and Region
02 févr. 2022 08h58 HE
|
Research and Markets
Dublin, Feb. 02, 2022 (GLOBE NEWSWIRE) -- The "Clinical Research Services Market Research Report by Services, by Indication, by Deployment, by End User, by Region - Global Forecast to 2027 -...
Outlook on the TIGIT Inhibitor Industry 2022 - Key Drivers and Challenges
21 déc. 2021 04h53 HE
|
Research and Markets
Dublin, Dec. 21, 2021 (GLOBE NEWSWIRE) -- The "Global TIGIT Inhibitor Drug Opportunity & Clinical Research Insight 2022" report has been added to ResearchAndMarkets.com's offering. T-cell...
Worldwide Preclinical CRO Industry to 2026 - Featuring Eurofins Scientific, MD Biosciences and PPD Among Others
01 déc. 2021 09h18 HE
|
Research and Markets
Dublin, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The "Preclinical CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...
GCANRx Announces Initiation of Preclinical Study for Neuropsychiatric Cannabinoid Therapy
08 nov. 2021 07h50 HE
|
The Greater Cannabis Company, Inc.
BALTIMORE, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a biopharmaceutical company pioneering development of next generation cannabinoid...
Algernon Pharmaceuticals Establishes 6 hours as Optimum Treatment Period for DMT in Neuron Study
01 nov. 2021 07h00 HE
|
Algernon Pharmaceuticals
VANCOUVER, British Columbia, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
Worldwide Preclinical CRO Industry to 2028 - Featuring Wuxi App, Medpace and ICON Among Others
12 oct. 2021 07h43 HE
|
Research and Markets
Dublin, Oct. 12, 2021 (GLOBE NEWSWIRE) -- The "Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing, Bioanalysis & DMPK Studies), By End Use...
Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Anticipated to Grow Globally at a CAGR of 23.6% during 2021-26
11 oct. 2021 07h13 HE
|
Research and Markets
Dublin, Oct. 11, 2021 (GLOBE NEWSWIRE) -- The "Global Artificial Intelligence (AI) Enabled Drug Discovery and Clinical Trials Market Research Report: Forecast (2021-2026)" report has been added to...
Algernon Pharmaceuticals Confirms DMT Increased Growth of Neurons by 40% in Preclinical Study at Sub Hallucinogenic Dose
07 sept. 2021 07h30 HE
|
Algernon Pharmaceuticals
VANCOUVER, British Columbia, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage...
Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Preclinical Lasofoxifene Study in Endocrine-Resistant Breast Cancer
17 mai 2021 10h19 HE
|
Sermonix Pharmaceuticals LLC
Paper highlights the ability of lasofoxifene to inhibit primary tumor growth and reduce metastases in mouse models, both as monotherapy and in combination with palbociclibStudy results demonstrate...